ImmuneOncia Therapeutics Inc.
ImmuneOncia Therapeutics Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy | Advanced Cancer | Recruiting | Phase 1 | 2026-09-25 | NCT05276310 | |
| A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type | Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, extranodal nasal NK/T cell lymphoma, lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-09-24 | NCT04414163 | |
| A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors; TMB-H | Recruiting | Phase 2 | 2026-04-17 | NCT06365840 |